Publication|Articles|October 4, 2024
- Pharmaceutical Commerce - October 2024
- Volume 19
- Issue 5
Pharmaceutical Commerce - October 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Commerce October 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 2 years ago
Strengthening the Chainalmost 2 years ago
A Sense of Urgencyalmost 2 years ago
Conference Connect: The Twists and Turns in Pharma Traceabilityalmost 2 years ago
Tapping the Value of Conscientious Stewardshipalmost 2 years ago
Specialty Pharmacy: The Trends Shaping Best Practicesalmost 2 years ago
Three Key Pharmaceutical Logistics Challenges to Monitoralmost 2 years ago
Keeping Do-Not-Freeze Injectable Drugs Safe Through the Last Milealmost 2 years ago
Key Elements for Success in Pharma M&A Integrationalmost 2 years ago
The Latest Surrounding Rising Medicare Part D Premiumsalmost 2 years ago
Reflections on IRA Drug Pricing NegotiationsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Will PBMs' TrumpRx Price Pledge Reach Prescribers?
2
AI In Pharmacovigilance: The Commercial and Market-Access Imperative
3
Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine
4
Why IAG Added Kuala Lumpur to Its Cold Chain Network
5

